Labcorp Holdings Income After Taxes 2010-2025 | LH
Labcorp Holdings annual/quarterly income after taxes history and growth rate from 2010 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Labcorp Holdings income after taxes for the quarter ending March 31, 2025 was $213M, a 6.7% decline year-over-year.
- Labcorp Holdings income after taxes for the twelve months ending March 31, 2025 was $0.732B, a 82.81% increase year-over-year.
- Labcorp Holdings annual income after taxes for 2024 was $0.747B, a 96.4% increase from 2023.
- Labcorp Holdings annual income after taxes for 2023 was $0.38B, a 62.09% decline from 2022.
- Labcorp Holdings annual income after taxes for 2022 was $1.004B, a 54.34% decline from 2021.
| Labcorp Holdings Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $747 |
| 2023 | $380 |
| 2022 | $1,004 |
| 2021 | $2,198 |
| 2020 | $1,557 |
| 2019 | $825 |
| 2018 | $884 |
| 2017 | $1,233 |
| 2016 | $713 |
| 2015 | $439 |
| 2014 | $513 |
| 2013 | $575 |
| 2012 | $585 |
| 2011 | $533 |
| 2010 | $572 |
| 2009 | $556 |
| Labcorp Holdings Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2025-03-31 | $213 |
| 2024-12-31 | $144 |
| 2024-09-30 | $170 |
| 2024-06-30 | $206 |
| 2024-03-31 | $228 |
| 2023-12-31 | $-167 |
| 2023-09-30 | $184 |
| 2023-06-30 | $155 |
| 2023-03-31 | $208 |
| 2022-12-31 | $-34 |
| 2022-09-30 | $277 |
| 2022-06-30 | $268 |
| 2022-03-31 | $492 |
| 2021-12-31 | $372 |
| 2021-09-30 | $588 |
| 2021-06-30 | $468 |
| 2021-03-31 | $770 |
| 2020-12-31 | $939 |
| 2020-09-30 | $704 |
| 2020-06-30 | $232 |
| 2020-03-31 | $-317 |
| 2019-12-31 | $227 |
| 2019-09-30 | $221 |
| 2019-06-30 | $191 |
| 2019-03-31 | $186 |
| 2018-12-31 | $158 |
| 2018-09-30 | $319 |
| 2018-06-30 | $234 |
| 2018-03-31 | $173 |
| 2017-12-31 | $690 |
| 2017-09-30 | $174 |
| 2017-06-30 | $185 |
| 2017-03-31 | $183 |
| 2016-12-31 | $164 |
| 2016-09-30 | $180 |
| 2016-06-30 | $204 |
| 2016-03-31 | $164 |
| 2015-12-31 | $110 |
| 2015-09-30 | $155 |
| 2015-06-30 | $170 |
| 2015-03-31 | $3 |
| 2014-12-31 | $120 |
| 2014-09-30 | $138 |
| 2014-06-30 | $142 |
| 2014-03-31 | $114 |
| 2013-12-31 | $127 |
| 2013-09-30 | $149 |
| 2013-06-30 | $152 |
| 2013-03-31 | $148 |
| 2012-12-31 | $121 |
| 2012-09-30 | $148 |
| 2012-06-30 | $154 |
| 2012-03-31 | $162 |
| 2011-12-31 | $138 |
| 2011-09-30 | $138 |
| 2011-06-30 | $127 |
| 2011-03-31 | $131 |
| 2010-12-31 | $135 |
| 2010-09-30 | $143 |
| 2010-06-30 | $157 |
| 2010-03-31 | $136 |
| 2009-12-31 | $146 |
| 2009-09-30 | $135 |
| 2009-06-30 | $139 |
| 2009-03-31 | $136 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.089B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.067B | 27.09 |
| CVS Health (CVS) | United States | $78.811B | 9.80 |
| Elevance Health (ELV) | United States | $66.101B | 8.89 |
| Cencora (COR) | United States | $56.558B | 19.68 |
| DiDi Global (DIDIY) | China | $24.238B | 25.75 |
| Natera (NTRA) | United States | $19.248B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.897B | 0.00 |
| ICON (ICLR) | Ireland | $14.657B | 14.10 |
| CochLear (CHEOY) | Australia | $13.278B | 0.00 |
| Solventum (SOLV) | United States | $12.626B | 13.37 |
| Medpace Holdings (MEDP) | United States | $12.299B | 32.55 |
| Revvity (RVTY) | United States | $10.708B | 18.58 |
| Viatris (VTRS) | United States | $10.563B | 3.63 |
| Avantor (AVTR) | United States | $9.404B | 13.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.886B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.654B | 16.96 |
| HealthEquity (HQY) | United States | $8.544B | 37.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.505B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.851B | 32.64 |
| Amplifon S.p.A (AMFPF) | Italy | $3.871B | 21.19 |
| BrightSpring Health Services (BTSG) | United States | $3.746B | 34.37 |
| Sotera Health (SHC) | United States | $3.382B | 19.22 |
| GeneDx Holdings (WGS) | United States | $2.953B | 68.10 |
| Surgery Partners (SGRY) | United States | $2.867B | 37.28 |
| Concentras Parent (CON) | United States | $2.615B | 15.11 |
| Organon (OGN) | United States | $2.610B | 2.77 |
| Alignment Healthcare (ALHC) | United States | $2.572B | 0.00 |
| Progyny (PGNY) | United States | $2.014B | 44.34 |
| Premier (PINC) | United States | $1.772B | 13.45 |
| GoodRx Holdings (GDRX) | United States | $1.747B | 34.93 |
| PACS (PACS) | United States | $1.710B | 0.00 |
| Ardent Health (ARDT) | United States | $1.528B | 6.51 |
| Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.213B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.065B | 8.10 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.791B | 0.00 |
| CareDx (CDNA) | United States | $0.716B | 11.18 |
| AMN Healthcare Services Inc (AMN) | United States | $0.712B | 6.67 |
| Embecta (EMBC) | United States | $0.611B | 4.11 |
| So-Young (SY) | China | $0.501B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.479B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
| Nutex Health (NUTX) | United States | $0.467B | 7.06 |
| LifeMD (LFMD) | United States | $0.459B | 0.00 |
| Omada Health (OMDA) | $0.455B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.455B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.454B | 10.23 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.369B | 0.00 |
| Enhabit (EHAB) | United States | $0.338B | 27.83 |
| Oncology Institute (TOI) | United States | $0.329B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.270B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.096B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| KindlyMD (NAKA) | United States | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.013B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |